Mitigating overdiagnosis and overtreatment in breast cancer: what is the role of the pathologist? - Suppr | 超能文献

Mitigating overdiagnosis and overtreatment in breast cancer: what is the role of the pathologist?

作者信息

Calhoun Benjamin C, Livasy Chad A

机构信息

From the Department of Pathology, Carolinas Medical Center, Charlotte, North Carolina (Drs Calhoun and Livasy); and the Department of Pathology, University of North Carolina, Chapel Hill (Dr Livasy). Dr Calhoun is now with the Department of Anatomic Pathology, Cleveland Clinic, Cleveland, Ohio.

出版信息

Arch Pathol Lab Med. 2014 Nov;138(11):1428-31. doi: 10.5858/arpa.2013-0763-ED. Epub 2014 Mar 14.

DOI:10.5858/arpa.2013-0763-ED

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Mitigating overdiagnosis and overtreatment in breast cancer: what is the role of the pathologist?

Arch Pathol Lab Med. 2014 Nov;138(11):1428-31. doi: 10.5858/arpa.2013-0763-ED. Epub 2014 Mar 14.

2

The diagnosis and management of pre-invasive breast disease--current challenges, future hopes.乳腺疾病癌前病变的诊断与管理——当前挑战与未来希望

Breast Cancer Res. 2003;5(5):248-9. doi: 10.1186/bcr641. Epub 2003 Jul 28.

3

The diagnosis and management of pre-invasive breast disease: another point of view.乳腺疾病癌前病变的诊断与管理：另一种观点

Breast Cancer Res. 2004;6(1):E3; discussion E4. doi: 10.1186/bcr740.

4

A Call for Change in the Diagnosis and Treatment of Patients with Ductal Carcinoma In Situ: An Opportunity to Minimize Overdiagnosis and Overtreatment.呼吁改变导管原位癌患者的诊断与治疗：减少过度诊断和过度治疗的契机

Breast J. 2015 Nov-Dec;21(6):575-8. doi: 10.1111/tbj.12526.

5

The diagnosis and management of pre-invasive breast disease: ductal carcinoma in situ (DCIS) and atypical ductal hyperplasia (ADH)--current definitions and classification.乳腺原位癌（DCIS）和非典型导管增生（ADH）等乳腺浸润前疾病的诊断与管理——当前定义和分类

Breast Cancer Res. 2003;5(5):254-7. doi: 10.1186/bcr623. Epub 2003 Jul 29.

6

The LORIS Trial: Addressing overtreatment of ductal carcinoma in situ.LORIS试验：解决导管原位癌的过度治疗问题。

Clin Oncol (R Coll Radiol). 2015 Jan;27(1):6-8. doi: 10.1016/j.clon.2014.09.015. Epub 2014 Nov 3.

7

Overdiagnosis and overtreatment of breast cancer: microsimulation modelling estimates based on observed screen and clinical data.乳腺癌的过度诊断与过度治疗：基于观察到的筛查及临床数据的微观模拟模型估计

Breast Cancer Res. 2006;8(1):202. doi: 10.1186/bcr1369. Epub 2005 Dec 21.

8

[Clinical aspects and treatment of "minimal" forms of breast cancer].["乳腺癌“微小”形式的临床特征与治疗"]

Vopr Onkol. 1983;29(5):28-33.

9

Definition of precancerous and high-risk mammary lesions.癌前和高危乳腺病变的定义。

Can J Surg. 1985 May;28(3):248-51.

10

Can mammographic findings help discriminate between atypical ductal hyperplasia and ductal carcinoma in situ after needle core biopsy?在针芯活检后，乳腺钼靶检查结果能否有助于鉴别非典型导管增生和导管原位癌？

Breast. 2008 Jun;17(3):282-8. doi: 10.1016/j.breast.2007.10.016. Epub 2007 Dec 11.

引用本文的文献

1

Prevalence of breast and ovarian cancer subtypes in Hispanic populations from Puerto Rico.波多黎各西班牙裔人群中乳腺癌和卵巢癌亚型的流行情况。

BMC Cancer. 2018 Nov 27;18(1):1177. doi: 10.1186/s12885-018-5077-z.

2

Management of flat epithelial atypia on breast core biopsy may be individualized based on correlation with imaging studies.乳腺核心活检中扁平上皮不典型增生的处理可根据与影像学研究的相关性进行个体化。

Mod Pathol. 2015 May;28(5):670-6. doi: 10.1038/modpathol.2014.159. Epub 2014 Nov 21.